Cargando…
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
SIMPLE SUMMARY: Colorectal cancer is a frequent and lethal neoplasm. The tumor often creates new vessels to grow and spread—a process called ‘angiogenesis’. Therefore, drugs blocking angiogenesis are effective against this malignancy. On the other side, immune checkpoint inhibitors, which unleash th...
Autores principales: | Maiorano, Brigida Anna, Parisi, Alessandro, Maiello, Evaristo, Ciardiello, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604892/ https://www.ncbi.nlm.nih.gov/pubmed/36294987 http://dx.doi.org/10.3390/life12101552 |
Ejemplares similares
-
The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy
por: Maiorano, Brigida Anna, et al.
Publicado: (2022) -
Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
por: Maiorano, Brigida Anna, et al.
Publicado: (2023) -
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review
por: Maiorano, Brigida Anna, et al.
Publicado: (2022) -
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
por: Maiorano, Brigida Anna, et al.
Publicado: (2022) -
Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
por: Maiorano, Brigida Anna, et al.
Publicado: (2021)